nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone furoate—CYP3A4—Temozolomide—malignant glioma	0.899	1	CbGbCtD
Fluticasone furoate—Impaired healing—Carmustine—malignant glioma	0.00765	0.111	CcSEcCtD
Fluticasone furoate—Menorrhagia—Temozolomide—malignant glioma	0.00432	0.0624	CcSEcCtD
Fluticasone furoate—Herpes simplex—Temozolomide—malignant glioma	0.00347	0.0501	CcSEcCtD
Fluticasone furoate—Candida infection—Carmustine—malignant glioma	0.00316	0.0456	CcSEcCtD
Fluticasone furoate—Candida infection—Temozolomide—malignant glioma	0.00305	0.0441	CcSEcCtD
Fluticasone furoate—Triamcinolone—BCHE—malignant glioma	0.00225	0.379	CrCbGaD
Fluticasone furoate—Bronchitis—Temozolomide—malignant glioma	0.00193	0.0279	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Carmustine—malignant glioma	0.00163	0.0236	CcSEcCtD
Fluticasone furoate—Visual impairment—Carmustine—malignant glioma	0.0016	0.0231	CcSEcCtD
Fluticasone furoate—Pharyngitis—Temozolomide—malignant glioma	0.00159	0.023	CcSEcCtD
Fluticasone furoate—Connective tissue disorder—Temozolomide—malignant glioma	0.00158	0.0228	CcSEcCtD
Fluticasone furoate—Eye disorder—Carmustine—malignant glioma	0.00155	0.0224	CcSEcCtD
Fluticasone furoate—Visual impairment—Temozolomide—malignant glioma	0.00155	0.0224	CcSEcCtD
Fluticasone furoate—Eye disorder—Temozolomide—malignant glioma	0.0015	0.0217	CcSEcCtD
Fluticasone furoate—Immune system disorder—Temozolomide—malignant glioma	0.00145	0.021	CcSEcCtD
Fluticasone furoate—Mediastinal disorder—Temozolomide—malignant glioma	0.00145	0.0209	CcSEcCtD
Fluticasone furoate—Back pain—Carmustine—malignant glioma	0.0014	0.0202	CcSEcCtD
Fluticasone furoate—Tremor—Carmustine—malignant glioma	0.00136	0.0196	CcSEcCtD
Fluticasone furoate—Back pain—Temozolomide—malignant glioma	0.00135	0.0195	CcSEcCtD
Fluticasone furoate—Agitation—Carmustine—malignant glioma	0.00133	0.0192	CcSEcCtD
Fluticasone furoate—Dexamethasone—CYP2B6—malignant glioma	0.00132	0.221	CrCbGaD
Fluticasone furoate—Tremor—Temozolomide—malignant glioma	0.00131	0.0189	CcSEcCtD
Fluticasone furoate—Agitation—Temozolomide—malignant glioma	0.00128	0.0186	CcSEcCtD
Fluticasone furoate—Angioedema—Temozolomide—malignant glioma	0.00128	0.0185	CcSEcCtD
Fluticasone furoate—Palpitations—Temozolomide—malignant glioma	0.00124	0.0178	CcSEcCtD
Fluticasone furoate—Cough—Temozolomide—malignant glioma	0.00122	0.0176	CcSEcCtD
Fluticasone furoate—Infection—Carmustine—malignant glioma	0.00117	0.0169	CcSEcCtD
Fluticasone furoate—Anaphylactic shock—Temozolomide—malignant glioma	0.00114	0.0165	CcSEcCtD
Fluticasone furoate—Infection—Temozolomide—malignant glioma	0.00113	0.0164	CcSEcCtD
Fluticasone furoate—Nervous system disorder—Temozolomide—malignant glioma	0.00112	0.0162	CcSEcCtD
Fluticasone furoate—Dyspnoea—Carmustine—malignant glioma	0.00105	0.0152	CcSEcCtD
Fluticasone furoate—Triamcinolone—PTGS2—malignant glioma	0.00104	0.174	CrCbGaD
Fluticasone furoate—Dyspnoea—Temozolomide—malignant glioma	0.00102	0.0147	CcSEcCtD
Fluticasone furoate—Body temperature increased—Carmustine—malignant glioma	0.000933	0.0135	CcSEcCtD
Fluticasone furoate—Urticaria—Temozolomide—malignant glioma	0.000906	0.0131	CcSEcCtD
Fluticasone furoate—Body temperature increased—Temozolomide—malignant glioma	0.000902	0.013	CcSEcCtD
Fluticasone furoate—Hypersensitivity—Carmustine—malignant glioma	0.00087	0.0126	CcSEcCtD
Fluticasone furoate—Betamethasone—PTGS2—malignant glioma	0.000851	0.143	CrCbGaD
Fluticasone furoate—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.000845	0.0329	CbGpPWpGaD
Fluticasone furoate—Hypersensitivity—Temozolomide—malignant glioma	0.000841	0.0121	CcSEcCtD
Fluticasone furoate—Diarrhoea—Carmustine—malignant glioma	0.000808	0.0117	CcSEcCtD
Fluticasone furoate—Dizziness—Carmustine—malignant glioma	0.000781	0.0113	CcSEcCtD
Fluticasone furoate—Diarrhoea—Temozolomide—malignant glioma	0.000781	0.0113	CcSEcCtD
Fluticasone furoate—Dizziness—Temozolomide—malignant glioma	0.000754	0.0109	CcSEcCtD
Fluticasone furoate—Rash—Carmustine—malignant glioma	0.000744	0.0108	CcSEcCtD
Fluticasone furoate—Dermatitis—Carmustine—malignant glioma	0.000744	0.0107	CcSEcCtD
Fluticasone furoate—Headache—Carmustine—malignant glioma	0.00074	0.0107	CcSEcCtD
Fluticasone furoate—Rash—Temozolomide—malignant glioma	0.000719	0.0104	CcSEcCtD
Fluticasone furoate—Dermatitis—Temozolomide—malignant glioma	0.000719	0.0104	CcSEcCtD
Fluticasone furoate—Headache—Temozolomide—malignant glioma	0.000715	0.0103	CcSEcCtD
Fluticasone furoate—Nausea—Carmustine—malignant glioma	0.000701	0.0101	CcSEcCtD
Fluticasone furoate—Nausea—Temozolomide—malignant glioma	0.000678	0.00979	CcSEcCtD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—NF1—malignant glioma	0.000677	0.0263	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.000572	0.0222	CbGpPWpGaD
Fluticasone furoate—NR3C1—Signaling events mediated by HDAC Class II—YWHAE—malignant glioma	0.00055	0.0214	CbGpPWpGaD
Fluticasone furoate—ABCB1—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000541	0.021	CbGpPWpGaD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000515	0.02	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—TFRC—malignant glioma	0.000513	0.02	CbGpPWpGaD
Fluticasone furoate—Dexamethasone—PTGS2—malignant glioma	0.000495	0.0831	CrCbGaD
Fluticasone furoate—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000485	0.0189	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PIM1—malignant glioma	0.000481	0.0187	CbGpPWpGaD
Fluticasone furoate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—malignant glioma	0.000476	0.0185	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MYB—malignant glioma	0.000449	0.0175	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—SOX2—malignant glioma	0.000444	0.0173	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—PPARG—malignant glioma	0.000435	0.0169	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—RUNX3—malignant glioma	0.000433	0.0169	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000421	0.0164	CbGpPWpGaD
Fluticasone furoate—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—NCOR1—malignant glioma	0.0004	0.0156	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000394	0.0153	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.00035	0.0136	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000333	0.013	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—NDRG1—malignant glioma	0.000322	0.0125	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000317	0.0124	CbGpPWpGaD
Fluticasone furoate—NR3C1—Circadian Clock—NCOR1—malignant glioma	0.000292	0.0113	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptors—PPARG—malignant glioma	0.000281	0.0109	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—GDNF—malignant glioma	0.000279	0.0109	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—GJA1—malignant glioma	0.000277	0.0108	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.00027	0.0105	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.000256	0.00998	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL12A—malignant glioma	0.000255	0.00993	CbGpPWpGaD
Fluticasone furoate—NR3C1—Circadian Clock—HIF1A—malignant glioma	0.000246	0.00956	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—malignant glioma	0.00024	0.00934	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—MYB—malignant glioma	0.000237	0.00921	CbGpPWpGaD
Fluticasone furoate—NR3C1—Transcription factor regulation in adipogenesis—TNF—malignant glioma	0.000231	0.00899	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.000229	0.00889	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—malignant glioma	0.000226	0.00877	CbGpPWpGaD
Fluticasone furoate—NR3C1—Nuclear Receptor transcription pathway—PPARG—malignant glioma	0.000222	0.00864	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000216	0.00841	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000214	0.00833	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—NCOR1—malignant glioma	0.000214	0.00832	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—HLA-A—malignant glioma	0.000212	0.00824	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—HIF1A—malignant glioma	0.000203	0.00788	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000202	0.00784	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—TFRC—malignant glioma	0.000199	0.00775	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000199	0.00774	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-C—malignant glioma	0.000189	0.00734	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—NOTCH1—malignant glioma	0.000187	0.00727	CbGpPWpGaD
Fluticasone furoate—NR3C1—Endoderm Differentiation—APC—malignant glioma	0.000183	0.00711	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.000178	0.00691	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.000178	0.00691	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of Androgen receptor activity—MDM2—malignant glioma	0.000176	0.00683	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000175	0.0068	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000172	0.00671	CbGpPWpGaD
Fluticasone furoate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000165	0.00642	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—malignant glioma	0.000165	0.0064	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000163	0.00636	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL12B—malignant glioma	0.00016	0.00624	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—NCOR1—malignant glioma	0.000147	0.0057	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.000146	0.00568	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000145	0.00565	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CDKN2A—malignant glioma	0.000145	0.00564	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000142	0.00551	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IFNG—malignant glioma	0.000141	0.0055	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—CXCL8—malignant glioma	0.000131	0.00511	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—HES1—malignant glioma	0.000127	0.00496	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—IL2—malignant glioma	0.000126	0.00489	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—malignant glioma	0.000125	0.00485	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—malignant glioma	0.000124	0.00482	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—HIF1A—malignant glioma	0.000123	0.0048	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—TERT—malignant glioma	0.000119	0.00464	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MMP9—malignant glioma	0.000119	0.00463	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—PTEN—malignant glioma	0.000118	0.0046	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000118	0.00459	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—malignant glioma	0.000116	0.00451	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—HIF1A—malignant glioma	0.000114	0.00444	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—PDGFRA—malignant glioma	0.000112	0.00437	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-B—malignant glioma	0.000112	0.00434	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—IL2—malignant glioma	0.000111	0.00431	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.00011	0.00429	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000107	0.00418	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.000107	0.00415	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—PPARG—malignant glioma	0.000105	0.00409	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000104	0.00406	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—HLA-A—malignant glioma	0.000103	0.00402	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000102	0.00395	CbGpPWpGaD
Fluticasone furoate—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	9.88e-05	0.00384	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—MYC—malignant glioma	9.82e-05	0.00382	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	9.31e-05	0.00362	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—malignant glioma	8.74e-05	0.0034	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CD80—malignant glioma	8.72e-05	0.00339	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	8.68e-05	0.00338	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	8.56e-05	0.00333	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—malignant glioma	8.51e-05	0.00331	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—COX8A—malignant glioma	8.49e-05	0.0033	CbGpPWpGaD
Fluticasone furoate—NR3C1—AP-1 transcription factor network—TP53—malignant glioma	8.07e-05	0.00314	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—FTH1—malignant glioma	7.76e-05	0.00302	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	7.52e-05	0.00293	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	7.42e-05	0.00289	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NOTCH3—malignant glioma	7.32e-05	0.00285	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—TP53—malignant glioma	7.11e-05	0.00277	CbGpPWpGaD
Fluticasone furoate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	7.02e-05	0.00273	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	6.92e-05	0.00269	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—RTEL1—malignant glioma	6.92e-05	0.00269	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IFNG—malignant glioma	6.89e-05	0.00268	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	6.79e-05	0.00264	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—IL1B—malignant glioma	6.64e-05	0.00258	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—CASP3—malignant glioma	6.63e-05	0.00258	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	6.62e-05	0.00258	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	6.6e-05	0.00257	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NOTCH2—malignant glioma	6.56e-05	0.00255	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	6.51e-05	0.00253	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—STAT3—malignant glioma	6.44e-05	0.00251	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CXCL8—malignant glioma	6.41e-05	0.00249	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	6.15e-05	0.00239	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL1B—malignant glioma	6.15e-05	0.00239	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—CASP3—malignant glioma	6.14e-05	0.00239	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—IL2—malignant glioma	6.13e-05	0.00238	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	6.1e-05	0.00237	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTT1—malignant glioma	6.09e-05	0.00237	CbGpPWpGaD
Fluticasone furoate—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—malignant glioma	6.06e-05	0.00236	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	6.01e-05	0.00234	CbGpPWpGaD
Fluticasone furoate—NR3C1—Glucocorticoid receptor regulatory network—AKT1—malignant glioma	6e-05	0.00234	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—PTGS1—malignant glioma	5.7e-05	0.00222	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—CDKN2B—malignant glioma	5.64e-05	0.00219	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	5.62e-05	0.00219	CbGpPWpGaD
Fluticasone furoate—NR3C1—Adipogenesis—TNF—malignant glioma	5.58e-05	0.00217	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	5.54e-05	0.00216	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NCOR1—malignant glioma	5.35e-05	0.00208	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—VEGFA—malignant glioma	5.21e-05	0.00203	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—DNMT3B—malignant glioma	5e-05	0.00195	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	4.95e-05	0.00193	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—HIST1H3B—malignant glioma	4.86e-05	0.00189	CbGpPWpGaD
Fluticasone furoate—NR3C1—SIDS Susceptibility Pathways—TNF—malignant glioma	4.82e-05	0.00188	CbGpPWpGaD
Fluticasone furoate—ABCB1—Allograft Rejection—TNF—malignant glioma	4.46e-05	0.00174	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	4.44e-05	0.00173	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	4.3e-05	0.00167	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—RTEL1—malignant glioma	4.27e-05	0.00166	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	4.25e-05	0.00165	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.22e-05	0.00164	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.16e-05	0.00162	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—NOTCH1—malignant glioma	4.06e-05	0.00158	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—COX8A—malignant glioma	3.98e-05	0.00155	CbGpPWpGaD
Fluticasone furoate—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	3.84e-05	0.00149	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—PPARG—malignant glioma	3.83e-05	0.00149	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—H3F3A—malignant glioma	3.75e-05	0.00146	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.62e-05	0.00141	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NOTCH3—malignant glioma	3.52e-05	0.00137	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	3.43e-05	0.00134	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	3.38e-05	0.00132	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—ASMT—malignant glioma	3.38e-05	0.00132	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	3.38e-05	0.00131	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	3.37e-05	0.00131	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	3.34e-05	0.0013	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	3.26e-05	0.00127	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—BCAN—malignant glioma	3.18e-05	0.00124	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NOTCH2—malignant glioma	3.16e-05	0.00123	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.1e-05	0.00121	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.03e-05	0.00118	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.95e-05	0.00115	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	2.84e-05	0.00111	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—CDKN2B—malignant glioma	2.72e-05	0.00106	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NCOR1—malignant glioma	2.58e-05	0.001	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.57e-05	0.001	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—IDH2—malignant glioma	2.56e-05	0.000997	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—COX8A—malignant glioma	2.45e-05	0.000953	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP2B6—malignant glioma	2.41e-05	0.000937	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.36e-05	0.00092	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.31e-05	0.0009	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—IDH1—malignant glioma	2.2e-05	0.000857	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.2e-05	0.000857	CbGpPWpGaD
Fluticasone furoate—NR3C1—Generic Transcription Pathway—MYC—malignant glioma	2.19e-05	0.00085	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.18e-05	0.00085	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SPHK1—malignant glioma	2.13e-05	0.000829	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CYP2C18—malignant glioma	2.09e-05	0.000813	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—ASMT—malignant glioma	2.08e-05	0.00081	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.01e-05	0.000781	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—BCAN—malignant glioma	1.96e-05	0.000762	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—NOTCH1—malignant glioma	1.96e-05	0.000761	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.94e-05	0.000755	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—PPARG—malignant glioma	1.85e-05	0.000718	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTT1—malignant glioma	1.69e-05	0.000657	CbGpPWpGaD
Fluticasone furoate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.64e-05	0.000638	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTGS1—malignant glioma	1.58e-05	0.000616	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—IDH2—malignant glioma	1.58e-05	0.000614	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.48e-05	0.000577	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—BCHE—malignant glioma	1.47e-05	0.000573	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—SLC5A5—malignant glioma	1.45e-05	0.000566	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—IDH1—malignant glioma	1.36e-05	0.000528	CbGpPWpGaD
Fluticasone furoate—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.34e-05	0.000521	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SPHK1—malignant glioma	1.31e-05	0.000511	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.29e-05	0.000501	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—GSTP1—malignant glioma	1.17e-05	0.000456	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CAT—malignant glioma	1.14e-05	0.000443	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—NCOR1—malignant glioma	1.08e-05	0.000419	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—MYC—malignant glioma	1.05e-05	0.000409	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTT1—malignant glioma	1.04e-05	0.000405	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTGS1—malignant glioma	9.75e-06	0.000379	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—BCHE—malignant glioma	9.07e-06	0.000353	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—SLC5A5—malignant glioma	8.96e-06	0.000348	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—CAV1—malignant glioma	8.77e-06	0.000341	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CG—malignant glioma	7.99e-06	0.000311	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PPARG—malignant glioma	7.71e-06	0.0003	CbGpPWpGaD
Fluticasone furoate—NR3C1—Gene Expression—AKT1—malignant glioma	7.3e-06	0.000284	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—GSTP1—malignant glioma	7.21e-06	0.000281	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CD—malignant glioma	7.02e-06	0.000273	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CAT—malignant glioma	7.02e-06	0.000273	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—NCOR1—malignant glioma	6.63e-06	0.000258	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CB—malignant glioma	6.12e-06	0.000238	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTGS2—malignant glioma	6.07e-06	0.000236	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—CAV1—malignant glioma	5.4e-06	0.00021	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PTEN—malignant glioma	5.29e-06	0.000206	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.92e-06	0.000192	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PPARG—malignant glioma	4.75e-06	0.000185	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.33e-06	0.000168	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.77e-06	0.000147	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTGS2—malignant glioma	3.74e-06	0.000145	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—PIK3CA—malignant glioma	3.73e-06	0.000145	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PTEN—malignant glioma	3.26e-06	0.000127	CbGpPWpGaD
Fluticasone furoate—ABCB1—Metabolism—AKT1—malignant glioma	3.05e-06	0.000119	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.3e-06	8.95e-05	CbGpPWpGaD
Fluticasone furoate—CYP3A4—Metabolism—AKT1—malignant glioma	1.88e-06	7.31e-05	CbGpPWpGaD
